Belite Bio, Inc (BLTE)
NASDAQ: BLTE · Real-Time Price · USD
159.56
-3.42 (-2.10%)
Oct 2, 2026, 4:00 PM EDT - Market closed
Belite Bio Market Cap
Belite Bio has a market cap or net worth of $6.43 billion as of October 2, 2026. Its market cap has increased by 166.27% in one year.
Market Cap
6.43B
Enterprise Value
5.93B
1-Year Change
166.27%
Ranking
Category
Stock Price
$159.56
ChartMarket Cap Chart
Since the IPO on April 29, 2022, Belite Bio's market cap has increased from $144.57M to $6.43B, an increase of 4,344.72%. That is a compound annual growth rate of 135.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 6.43B | 7.08% |
| Dec 31, 2025 | 6.00B | 207.97% |
| Dec 31, 2024 | 1.95B | 54.32% |
| Dec 29, 2023 | 1.26B | 68.44% |
| Dec 30, 2022 | 749.63M | 418.52% |
| Apr 29, 2022 | 144.57M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ionis Pharmaceuticals | 7.24B |
| Immunovant | 6.94B |
| Iovance Biotherapeutics | 6.44B |
| Rhythm Pharmaceuticals | 6.39B |
| Ligand Pharmaceuticals | 6.04B |
| CG Oncology | 5.97B |
| Kodiak Sciences | 5.92B |
| Scholar Rock Holding | 5.70B |